Bausch Health Companies (BHC) Treasury Shares (2010 - 2025)
Bausch Health Companies (BHC) reported Treasury Shares of $5.1 million for Q4 2025, up 168.42% on a YoY basis from $1.9 million in Q4 2024, and up 168.42% sequentially from $1.9 million in Q4 2024.
Bausch Health Companies (BHC) Treasury Shares (2010 - 2025) Analysis & Trends
Bausch Health Companies (BHC) has 3 years of Treasury Shares data on file, last reported at $72.0 million in Q4 2015.
- For the quarter ending Q4 2015, Treasury Shares changed N/A year-over-year to $72.0 million; the trailing twelve-month figure through Dec 2015 stood at $72.0 million (changed N/A YoY), and the FY2015 full-year result was $72.0 million, changed N/A from the prior year.
- Treasury Shares rose to $72.0 million in Q4 2015, from $20.0 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $5.1 million in Q4 2025 to a low of $1.2 million in Q4 2023.
- A 4-year average of $3.1 million and a median of $3.0 million in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares sank 71.43% in 2023 and jumped 168.42% in 2025, its largest moves.
- Tracing BHC's Treasury Shares over 3 years: stood at $66.9 million in 2011, then slumped by 70.1% to $20.0 million in 2013, then surged by 260.0% to $72.0 million in 2015.
- Business Quant data shows BHC's Treasury Shares at $72.0 million in Q4 2015, $20.0 million in Q2 2013, and $66.9 million in Q3 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.10 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2019 | 6.10 Mn |
| Dec 31, 2019 | 6.10 Mn |
| Dec 31, 2018 | 5.80 Mn |
| Dec 31, 2018 | 5.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Dec 31, 2015 | 72.00 Mn |
| Dec 31, 2015 | 1.50 Mn |